253 related articles for article (PubMed ID: 25098926)
21. Dynamic expression of TET1, TET2, and TET3 dioxygenases in mouse and human placentas throughout gestation.
Rakoczy J; Padmanabhan N; Krzak AM; Kieckbusch J; Cindrova-Davies T; Watson ED
Placenta; 2017 Nov; 59():46-56. PubMed ID: 29108636
[TBL] [Abstract][Full Text] [Related]
22. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
[TBL] [Abstract][Full Text] [Related]
23. TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma.
Mariani CJ; Vasanthakumar A; Madzo J; Yesilkanal A; Bhagat T; Yu Y; Bhattacharyya S; Wenger RH; Cohn SL; Nanduri J; Verma A; Prabhakar NR; Godley LA
Cell Rep; 2014 Jun; 7(5):1343-1352. PubMed ID: 24835990
[TBL] [Abstract][Full Text] [Related]
24. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
[TBL] [Abstract][Full Text] [Related]
25. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
26. Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients.
Yang Q; Wu K; Ji M; Jin W; He N; Shi B; Hou P
J Biomed Nanotechnol; 2013 Sep; 9(9):1607-16. PubMed ID: 23980508
[TBL] [Abstract][Full Text] [Related]
27. Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma.
Shi X; Yu Y; Luo M; Zhang Z; Shi S; Feng X; Chen Z; He J
PLoS One; 2016; 11(4):e0153100. PubMed ID: 27050164
[TBL] [Abstract][Full Text] [Related]
28. TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer.
Fu HL; Ma Y; Lu LG; Hou P; Li BJ; Jin WL; Cui DX
J Biomed Nanotechnol; 2014 Jul; 10(7):1217-30. PubMed ID: 24804542
[TBL] [Abstract][Full Text] [Related]
29. TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells.
Secardin L; Limia CEG; di Stefano A; Bonamino MH; Saliba J; Kataoka K; Rehen SK; Raslova H; Marty C; Ogawa S; Vainchenker W; Monte-Mor BDCR; Plo I
Stem Cell Res; 2020 Apr; 44():101755. PubMed ID: 32193150
[TBL] [Abstract][Full Text] [Related]
30. Ten-eleven translocation 1 (TET1) methylation is associated with childhood asthma and traffic-related air pollution.
Somineni HK; Zhang X; Biagini Myers JM; Kovacic MB; Ulm A; Jurcak N; Ryan PH; Khurana Hershey GK; Ji H
J Allergy Clin Immunol; 2016 Mar; 137(3):797-805.e5. PubMed ID: 26684294
[TBL] [Abstract][Full Text] [Related]
31. Quantification of Oxidized 5-Methylcytosine Bases and TET Enzyme Activity.
Liu MY; DeNizio JE; Kohli RM
Methods Enzymol; 2016; 573():365-85. PubMed ID: 27372762
[TBL] [Abstract][Full Text] [Related]
32. Expression of TET and 5-HmC in Trophoblast Villi of Women with Normal Pregnancy and with Early Pregnancy Loss.
Wu AH; Yang DY; Liu YD; Chen X; Chen XL; Lu S; Chen SL
Curr Med Sci; 2018 Jun; 38(3):505-512. PubMed ID: 30074219
[TBL] [Abstract][Full Text] [Related]
33. Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer.
Yang L; Yu SJ; Hong Q; Yang Y; Shao ZM
PLoS One; 2015; 10(7):e0133896. PubMed ID: 26207381
[TBL] [Abstract][Full Text] [Related]
34. Analysis of TET expression/activity and 5mC oxidation during normal and malignant germ cell development.
Nettersheim D; Heukamp LC; Fronhoffs F; Grewe MJ; Haas N; Waha A; Honecker F; Waha A; Kristiansen G; Schorle H
PLoS One; 2013; 8(12):e82881. PubMed ID: 24386123
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
36. Quantitative assessment of Tet-induced oxidation products of 5-methylcytosine in cellular and tissue DNA.
Liu S; Wang J; Su Y; Guerrero C; Zeng Y; Mitra D; Brooks PJ; Fisher DE; Song H; Wang Y
Nucleic Acids Res; 2013 Jul; 41(13):6421-9. PubMed ID: 23658232
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins.
Pirola CJ; Scian R; Gianotti TF; Dopazo H; Rohr C; Martino JS; Castaño GO; Sookoian S
Medicine (Baltimore); 2015 Sep; 94(36):e1480. PubMed ID: 26356709
[TBL] [Abstract][Full Text] [Related]
38. Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions-benign adenomas and inflammatory bowel disease.
Dziaman T; Gackowski D; Guz J; Linowiecka K; Bodnar M; Starczak M; Zarakowska E; Modrzejewska M; Szpila A; Szpotan J; Gawronski M; Labejszo A; Liebert A; Banaszkiewicz Z; Klopocka M; Foksinski M; Marszalek A; Olinski R
Clin Epigenetics; 2018; 10():72. PubMed ID: 29875879
[TBL] [Abstract][Full Text] [Related]
39. Early de novo DNA methylation and prolonged demethylation in the muscle lineage.
Tsumagari K; Baribault C; Terragni J; Varley KE; Gertz J; Pradhan S; Badoo M; Crain CM; Song L; Crawford GE; Myers RM; Lacey M; Ehrlich M
Epigenetics; 2013 Mar; 8(3):317-32. PubMed ID: 23417056
[TBL] [Abstract][Full Text] [Related]
40. 5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy.
Vasanthakumar A; Godley LA
Cancer Genet; 2015 May; 208(5):167-77. PubMed ID: 25892122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
